Corrected: Hansoh Pharma eyes Q1 pre-marketing for $1bn IPO
Hansoh Pharmaceutical Group is planning to launch investor education for its $1bn Hong Kong IPO before the end of March.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: